Chanan-Khan, A. Et Al. 2015. Ibrutinib combined with bendamustine/rituximab (BR) in previously treated small lymphocytic lymphoma (SLL): analysis of patients in the HELIOS trial. LEUKEMIA & LYMPHOMA , vol.56 , 92-93.

Chanan-Khan, A., Fraser, G., Cramer, P., DEMİRKAN, F., Silva, R. S., Pylypenko, H., ... Grosicki, S.(2015). Ibrutinib combined with bendamustine/rituximab (BR) in previously treated small lymphocytic lymphoma (SLL): analysis of patients in the HELIOS trial. LEUKEMIA & LYMPHOMA , vol.56, 92-93.

Chanan-Khan, Asher Et Al. "Ibrutinib combined with bendamustine/rituximab (BR) in previously treated small lymphocytic lymphoma (SLL): analysis of patients in the HELIOS trial," LEUKEMIA & LYMPHOMA , vol.56, 92-93, 2015

Chanan-Khan, Asher Et Al. "Ibrutinib combined with bendamustine/rituximab (BR) in previously treated small lymphocytic lymphoma (SLL): analysis of patients in the HELIOS trial." LEUKEMIA & LYMPHOMA , vol.56, pp.92-93, 2015

Chanan-Khan, A. Et Al. (2015) . "Ibrutinib combined with bendamustine/rituximab (BR) in previously treated small lymphocytic lymphoma (SLL): analysis of patients in the HELIOS trial." LEUKEMIA & LYMPHOMA , vol.56, pp.92-93.

@article{article, author={Asher Chanan-Khan Et Al. }, title={Ibrutinib combined with bendamustine/rituximab (BR) in previously treated small lymphocytic lymphoma (SLL): analysis of patients in the HELIOS trial}, journal={LEUKEMIA & LYMPHOMA}, year=2015, pages={92-93} }